Efficacy and safety of palbociclib and ribociclib in patients with estrogen and/or progesterone receptor positive, HER2 receptor negative metastatic breast cancer in routine clinic...

por Sushmita Rath, Prahalad Elamarthi, Pallavi Parab, Seema Gulia, Ravindra Nandhana, Smruti Mokal, Yogesh Kembhavi, Prema Perumal, Jyoti Bajpai, Jaya Ghosh, Sudeep Gupta
Publicado 2021